S005 Journal Watching
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Back by popular demand, Journal Watching symposium reviews the literature to digest and summarize the highest impact articles to save you time and keep you up to date. Experts from across the country come together for a session that is high yield, showcasing advances in Melanoma research, Dermatopathology, Surgical Dermatology, Medical and Pediatric Dermatology. Bring your questions, there will be time at the end for discussion.
LEARNING OBJECTIVES
Recognize advances in the diagnosis and/or management of melanoma.
Describe the latest discoveries in dermatologic surgery.
Identify current issues in medical and pediatric dermatology.
SCHEDULE
5:00 PM
Welcome & Introduction
Mary Wu Chang, MD, FAAD
5:05 PM
Basic Science/Genomics Update
Kavita Sarin, MD, PhD, FAAD
5:28 PM
Pediatric Dermatology News
Mary Wu Chang, MD, FAAD
5:51 PM
Melanoma Update
Hensin Tsao, MD, PhD, FAAD
6:14 PM
Dermatopathology News
Carole Bitar, MD, FAAD
6:37 PM
Mohs & Dermatologic Surgery
Murad Alam, MD, FAAD
7:00 PM
Lasers & Cosmetic Dermatology: What's Hot
Sandy Sharon Tsao, MD, FAAD
7:23 PM
Advances in Medical Dermatology
Jeffrey Phillip Callen, MD, FAAD
7:46 PM
Q & A
SPEAKERS
Murad Alam, MD, FAAD
Carole Bitar, MD, FAAD
Jeffrey Phillip Callen, MD, FAAD
Mary Wu Chang, MD, FAAD
Kavita Sarin, MD, PhD, FAAD
Hensin Tsao, MD, PhD, FAAD
Sandy Sharon Tsao, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Murad Alam, MD, FAAD
No financial relationships exist with ineligible companies.
Carole Bitar, MD, FAAD
No financial relationships exist with ineligible companies.
Jeffrey Phillip Callen, MD, FAAD
3M Pharmaceuticals – Stockholder Public Company(No Compensation Received); Abbott Laboratories – Stockholder Public Company(No Compensation Received); AbbVie – Stockholder Public Company(No Compensation Received); Allergan, Inc – Stockholder Public Company(No Compensation Received); Amgen – Stockholder Public Company(No Compensation Received); Biogen – Data Safety Monitoring Board(Honoraria); Celgene – Stockholder Public Company(No Compensation Received); Elsevier Inc. – Other(Other Financial Benefit); EMD Serono – Other(Honoraria); JAMA – Other(No Compensation Received); Johnson and Johnson – Stockholder Public Company(No Compensation Received); Merck & Co., Inc – Stockholder Public Company(No Compensation Received); Pfizer Inc. – Stockholder Public Company(No Compensation Received); Procter & Gamble Company – Stockholder Public Company(No Compensation Received); Proivant – Data Safety Monitoring Board(Fees); UpToDate, Inc. – Other(Honoraria);
Mary Wu Chang, MD, FAAD
No financial relationships exist with ineligible companies.
Kavita Sarin, MD, PhD, FAAD
ChemoCentryx – Speaker(Fees); Myotherix – Consultant(Fees), Consultant(Stock Options); NFlection Therapeutics, Inc – Advisory Board(Fees), Advisory Board(Stock Options); Phoenicis – Consultant (1099 relationship)(Fees);
Hensin Tsao, MD, PhD, FAAD
Epiphany Dermatology – Advisory Board(Honoraria), Advisory Board(Stock Options); Massachusetts General Hospital – Employee(Salary); Oncobay Clinical – Consultant (1099 relationship)(Fees); UpToDate, Inc. – Other(Honoraria); Worldcare Clinical, LLC – Consultant (1099 relationship)(Fees);
Sandy Sharon Tsao, MD, FAAD
Epiphany Dermatology – Advisory Board(Stock); Lazarus AI – Consultant(Honoraria); Oncobay – Consultant(Honoraria); Oncobay Clinical – Consultant(Honoraria); UpToDate – Other(Honoraria); WorldCare Clinical LLC – Consultant (1099 relationship)(Honoraria);